Therapy for Children With Advanced Stage Neuroblastoma
Phase 2 Completed
153 enrolled 12 charts
Isotretinoin With or Without Dinutuximab, Aldesleukin, and Sargramostim Following Stem Cell Transplant in Treating Patients With Neuroblastoma
Phase 3 Completed
1,449 enrolled 17 charts
MIBG With Dinutuximab +/- Vorinostat
Phase 1 Completed
45 enrolled 16 charts
Study of Pembrolizumab Plus SurVaxM for Glioblastoma at First Recurrence
Phase 2 Completed
41 enrolled 15 charts
Safety Study of Dinutuximab Combined With Immunotherapy to Treat Neuroblastoma
Phase 2 Completed
24 enrolled
Wild-Type Reovirus in Combination With Sargramostim in Treating Younger Patients With High-Grade Relapsed or Refractory Brain Tumors
Phase 1 Completed
6 enrolled
Irinotecan Hydrochloride and Temozolomide With Temsirolimus or Dinutuximab in Treating Younger Patients With Refractory or Relapsed Neuroblastoma
Phase 2 Completed
73 enrolled 12 charts
GM-CSF Mouthwash for Preventing and Treating Mucositis in Patients Undergoing Radiation Therapy for Head and Neck Cancer
Phase 3 Completed
91 enrolled 16 charts
SPRING
Phase NA Completed
13 enrolled 13 charts
Biological Therapy, Sargramostim, and Isotretinoin in Treating Patients With Relapsed or Refractory Neuroblastoma
Phase 2 Completed
52 enrolled 11 charts
Combination Chemotherapy, Monoclonal Antibody, and Natural Killer Cells in Treating Young Patients With Recurrent or Refractory Neuroblastoma
Phase 1 Completed
34 enrolled
GAPVAC Phase I Trial in Newly Diagnosed Glioblastoma Patients
Phase 1 Completed
16 enrolled
ACT III
Phase 2 Completed
82 enrolled
ACT IV
Phase 3 Completed
745 enrolled
A Pilot Study of Immunotherapy Including Haploidentical NK Cell Infusion Following CD133+ Positively-Selected Autologous Hematopoietic Stem Cells in Children With High Risk Solid Tumors or Lymphomas
Phase 1 Completed
8 enrolled
Surgery in Treating Children With Neuroblastoma
Phase 3 Completed
968 enrolled
Vaccine Therapy and Sargramostim in Treating Patients With Malignant Glioma
Phase 1 Completed
9 enrolled
ACTIVATe
Phase 2 Completed
40 enrolled 9 charts
Vaccine Therapy, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
Phase 1 Completed
45 enrolled
Combination Chemotherapy in Treating Children With Neuroblastoma
Phase 3 Completed
573 enrolled
Combination Chemotherapy Followed by Bone Marrow and/or Peripheral Stem Cell Transplantation in Treating Patients With Recurrent Medulloblastoma or CNS Germ Cell Tumors
Phase 2 Completed
31 enrolled
Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Neuroblastoma
Phase 2 Completed
42 enrolled
Biological Therapy in Treating Patients With Glioblastoma Multiforme
Phase 2 Completed
40 enrolled
Monoclonal Antibody 3F8 and GM-CSF in Treating Young Patients With High-Risk, Refractory or Relapsed Neuroblastoma
Phase 1 Completed
32 enrolled
Monoclonal Antibody Therapy Plus Sargramostin in Treating Patients With Advanced Neuroblastoma
Phase 2 Completed
40 enrolled
Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid Tumors
Phase 2 Completed
Chemotherapy and Vaccine Therapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation and Interleukin-2 in Treating Patients With Recurrent or Refractory Brain Cancer
Phase 2 Completed
Biological Therapy Following Surgery and Radiation Therapy in Treating Patients With Primary or Recurrent Astrocytoma or Oligodendroglioma
Phase 2 Completed
60 enrolled
Biological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Cancer
Phase 2 Completed
40 enrolled
Multiple Therapies in Treating Patients With Advanced Neuroblastoma
Phase 2 Completed
Thiotepa Followed by Peripheral Stem Cell or Bone Marrow Transplant in Treating Patients With Malignant Glioma
Phase 2 Completed
40 enrolled
Biological Therapy in Treating Patients With Neuroblastoma That Has Not Responded to Previous Treatment
Phase 2 Completed
74 enrolled
Monoclonal Antibody Therapy With Sargramostim and Interleukin-2 in Treating Children With Neuroblastoma
Phase 1 Completed
6 enrolled
Vaccine Therapy and Sargramostim in Treating Patients With Sarcoma or Brain Tumor
Phase 1 Completed